Charles River Laboratories International Inc. closed 39.25% below its 52-week high of $274.77, which the company reached on ...
Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...
Charles Schwab Investment Management Inc. boosted its position in shares of Charles River Laboratories International, Inc.
SOLANA BEACH, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical ...
Smartleaf Asset Management LLC raised its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – ...
StockStory.org on MSN20h
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services StocksAs the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
Council’s executive committee voted Wednesday to recommend to the entire council that they extend the Downtown community ...
Edmonton Journal on MSN6d
Opinion: Edmonton should say no to subsidizing Daryl Katz — againEdmontonians were surprised to learn of an agreement between the City of Edmonton, the Government of Alberta, and OEG Sports ...
Building on the success of Rogers Place and surrounding developments, OEG Sports & Entertainment has signed a memorandum of ...
While all eyes & ears are on the US and the systemic dismantling and destruction of decades of science knowledge and ...
Zacks Investment Research on MSN2d
TRVI Stock Soars on Meeting Primary Goal in Chronic Cough StudyShares of Trevi Therapeutics TRVI surged 41% yesterday after it reported positive top-line data from the phase IIa RIVER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback